I'm in.

Starts on page 52:

https://static.cdfa.ca.gov/MCCP/document/MAUCRSA_Senate%20Bill%2094_2017.pdf

'Shaaaaaaarrk' I have never been deaf, dumb, blind, one legged or trading impaired. Can't speak for those that are ;)

So everyone has bailed on this little beauty?

News from California.

Didn't see your edit. Agreed, strange things can happen.

Maybe they were hungry? After the Poopzoo fiasco, they did do the deal in NM, so maybe I'm wrong?

They would file a S-3 and do their own IPO.

The leader of the pack is not going to RM into the swamp of someone elses dead share count.

Best case scenario here, is they acquire additional asset structures into their stable.

Agreed, I like contemplating probabilities and my mind is open to possibilities. However,

Cunic and Farinella are aholes and deserve to be cell mates:

https://www.sec.gov/litigation/litreleases/2017/lr23864.htm

And, sh!t stays awhile in the teeth: “We have become more selective with whom we choose to partner,"

https://mjbizdaily.com/steep-hill-nixes-pazoo-branded-testing-labs/

Still think they wait for the big board, and that means Federal capitulation.

sorry brother, Steep Hill tried this with another OTC ticker. It didn't end well for them and their rep took a hit. I bet they wait for they big board. JMO though

Glad I could add to the research board. I believe regulation is key to any real success in this sector.

Sessions ask Congress to reinstate the funds from the DOJ so he can resume putting your sister in jail for smoking a joint on the street. This is not a light handed tactic.

Ok, try this for starters:

https://www.massroots.com/news/senators-ok-state-medical-marijuana-protections-rejecting-sessions

Now that the Cole Memo probably stands, the cultivators are now free to expand their businesses in legal States and in such, more product tested. Best sector of the sector, testing.

I can only throw you the bone. You guys are smart, shouldn't be hard to verify :)

Session denied at the DOJ....Weed is protected at the State level.

Looks like they couldn't wait. +1 GBLX!

You guys are about to get spanked.


lol

It's a milestone day, boys. First harvest is in.

One of the best things I like about this company is they don't go around throwing PR's out like other stupid OTC pennies. That doesn't mean they aren't out their discussing their goals and intents. Makes for good detective work to find those nugs of info. Here's GB's "PR" on Texas:

http://www.bizjournals.com/houston/news/2017/02/23/while-texas-dithers-over-regulations-medical.html#i1

Seems some were surprised by Texas. Here is the update with clues from LA.

https://mjbizdaily.com/seven-firms-apply-run-lsus-medical-marijuana-operation/

5th is 2nd alternate. Texas won't pull its head out of its ass for some time, but kudos for responding to the children's infliction. Let's hope the 3 winners have their places secured and paid for...Poss is a Texan, right??

What's interesting is who they beat and the competition they face (the same) in Lousiana. That market won't be ass backwards as TX, and LSU provides research into the bio angle. (Boom)

I don't think so. The Texas program is about serving only the epilepsy diagnosis with CBD product. 3 large outfits will serve the small medical community well into 2020 with low profit margins and medicine that could be gained from wild hemp. You're missing the "close".

Close....

http://www.dps.texas.gov/rsd/CUP/index.htm

http://www.dps.texas.gov/rsd/CUP/docs/scoringMatrix.pdf

link don't work, mf. Search of sec.gov shows no transactions.

counter, https://www.leafly.com/news/industry/nevada-legalizing-july-1-is-your-business-ready

Ahh, I see. Same thing in my neighborhood.

Tomorrow, the work begins again. Nothing wizardry about that

HS?

High Schoolers??

High road, good.

Jumped this rocket 3/23 @.0197 after the bull pennant confirmation and fib retracement from the front load Monday. Ride the wave is indeed the correct move. Good luck in all your trades.

You seem like a solid helix.

The Promoter has put a date on to the runs end and other such musings. Curious your opinion of the interloper just walking into your orbit?

Am I the one?

Is SIPC the one?

It's freaking awesome. Revenue in 3 months.

good job today, kidz. very orderly.

Nice and orderly, bagholders. Plenty of time for you to get out and let the next in.

With proper motivation, the flock could run this volume to 200 million traded. If that happens, and motivation has commenced already, then 300% would allow the former bagholders to exit to make room for the newly motivated, causing swings of causation to bubble from the IPA metric without earnings or revenue, silly rabbit, I see 400% this week. BOOM!

Wouldn't that also give 50/50 odds that the breakout goes to .0016?

What's going on here?

Never heard of these guys before :-$

Impressive it held in today in the blood letting. Should take note of that fact.

Correction has been made.

http://ih.advfn.com/p.php?pid=nmona&article=72909176

10Q is due this week and I'm sure this will be updated, but this is the recent:

A/S is 250mm, although they removed 50mm to use in the S3 raise(which they are doing nicely).
O/S is listed at 66mm, including 25mm held by direct insiders.
Float is listed at 51mm.
Short interest as of 10/15 is 71K.
Market Cap with current numbers puts it at $29mm. TRT* is $210mm.

One of the better share structures out there, IMHO.

LAS VEGAS, Oct. 12, 2016 /PRNewswire/ -- Growblox Sciences, Inc. (otcqb:GBLX) is pleased to announce the filing of the first of several patent applications for life science inventions by its wholly-owned subsidiary, Growblox Life Sciences, LLC. The current provisional patent application covers complex-cannabinoid-containing mixtures capable of enhancing dopamine secretion and protect neurons from the mitochondrial-induced free radical damage that occurs during disease progression in the brains of patients with Parkinson's disease, Alzheimer's disease, Lewy Body Dementia, and Huntington's disease, among others. In an aging population, neurodegeneration associated with these disorders is a growing health burden according to the World Health Organization (2013). For the past two years, GB Sciences has been working towards the creation of novel, patentable cannabis-based formulations under the leadership of Dr. Andrea Small-Howard, Chief Science Officer of GB Sciences, Inc. "This patent application is the first in a series that were invented based on our novel approach to creating cannabis-based therapies. Unlike many other companies and researchers who try to reduce the natural complexity in the cannabis plant, we embrace it and it informs our therapeutic mixtures," said Dr. Small-Howard. "Additionally, we test our mixtures in disease systems that include a natural diversity of human cannabis-receptors, not just CB1 and CB2 receptors, which are the only receptors studied by many leading cannabinoid researchers. Our fast and efficient screening system then evaluates the effectiveness of the cannabis-based mixtures containing dozens of individually acting agents in order to make effective therapies for different diseases. We intend to start with Parkinson's disease because these patients are in great need of an effective therapeutic treatment. One additional benefit is that our Parkinson's treatment does not contain substantial amounts of the psychoactive compound, delta-9 tetrahydrocannabinol." GB Sciences' CEO, John Poss, said, "Our goal is to help the approximately one million patients in the US and ten million world-wide that are living with Parkinson's disease through our life science research, and we anticipate being able to use the same research processes to create additional innovative therapeutic options for other underserved patient groups in the coming months. Through our current patent application, GB Sciences is poised to participate in the US biopharmaceutical market for neurological disorders, which is projected to reach $128.6 billion by 2020. While there are many regulatory hurdles in front of us, this opportunity dramatically expands the revenue potential for our company over the next five years."

Market over reacted to the news, or sold off when it was supposed to, depends who you ask. If you're unable to trade support and resistance then holding this ticker will payoff in the long run IMO. Legal Weed in Nevada!

These guys just raised $6 million without the help of the penny thieves. Understand that point my friend. This isn't MCI* or VAP*